MORE►
NIH
Who Made This Year’s AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence
by Glenn Hunter | Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
by Nicole Ward, DRC Data Journalist |
Aug 1, 2024
OncoNano's innovative approach to cancer treatment leverages nanotechnology to bring tumors into the light.
MORE►
by Quincy Preston and Lance Murray |
Oct 20, 2023
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
MORE►
by David Seeley |
Sep 18, 2023
The award will help SMU biology professor Zhihao Wu determine if different "quality control pathways" in our bodies might be working together to repair damaged components in cells. The research could help lead to "new therapeutic targets" for hallmarks known to cause many human diseases, the university said.
MORE►
Philipp Scherer, associate director of UT Southwestern's Nutrition Obesity Research Center, delivers a President's Lecture Series exploration of obesity. [Photo: UTSW]
UT Southwestern Is Selected as One of 12 NIH Obesity Research Centers
by Lance Murray | Sep 28, 2022
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
MORE►
by David Seeley |
Apr 21, 2022
A team of UT Dallas bioengineers has developed a rapid test for viruses that delivers results as accurate as PCR lab tests within 30 minutes. The test works by attaching gold nanoparticles to antibodies against the virus being tested, then scanning them with two lasers.
Three months after winning the grand prize at the MassChallenge North Texas pitch competition, the team's leader, Dr. Zhenpeng Qin, is working to commercialize the technology through a new company, Avsana Labs.
Three months after winning the grand prize at the MassChallenge North Texas pitch competition, the team's leader, Dr. Zhenpeng Qin, is working to commercialize the technology through a new company, Avsana Labs.
MORE►
by David Seeley |
Oct 7, 2021
The award from the National Institutes of Health will help HSC lead the AI/Machine Learning Consortium to Advance Health Equity and Researcher Diversity, or AIM-AHEAD, program. The effort will bring together experts in community engagement, AI/ML, health equity research, data science training, and data infrastructure.
MORE►
by Alex Edwards |
Jun 1, 2020
DesignPlex Biomedical was given a royalty-free license by NASA to commercialize a new ventilator for coronavirus patients. Nanoscope Technologies got more than $2 million from the National Eye Institute to advance its gene therapy treatment.
MORE►
Photo: Michael Samples
UNT Researchers Testing Drug to Prevent Blindness Caused by Glaucoma
by Nicholas Sakelaris | Nov 17, 2016
Glaucoma is the second leading cause of blindness.
MORE►
